APOL1 risk variants, race, and progression of chronic kidney disease.

Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ, AASK Study Investigators, CRIC Study Investigators
N Engl J Med. 2013 369 (23): 2183-96

PMID: 24206458 · PMCID: PMC3969022 · DOI:10.1056/NEJMoa1310345

MeSH Terms (22)

Adult African Americans Aged Apolipoprotein L1 Apolipoproteins Creatinine Diabetes Complications Disease Progression Female Genetic Predisposition to Disease Glomerular Filtration Rate Humans Hypertension Kidney Failure, Chronic Lipoproteins, HDL Male Middle Aged Multivariate Analysis Polymorphism, Single Nucleotide Proteinuria Renal Insufficiency, Chronic Whites

Connections (1)

This publication is referenced by other Labnodes entities: